Cargando…

Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment

Glioblastoma (GBM), the most aggressive form of brain cancer, is characterized by a high level of molecular heterogeneity, and infiltration by various immune and stromal cell populations. Important advances have been made in deciphering the microenvironment of GBMs, but its association with existing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeanmougin, Marine, Håvik, Annette B., Cekaite, Lina, Brandal, Petter, Sveen, Anita, Meling, Torstein R., Ågesen, Trude H., Scheie, David, Heim, Sverre, Lothe, Ragnhild A., Lind, Guro E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191188/ https://www.ncbi.nlm.nih.gov/pubmed/32171051 http://dx.doi.org/10.1002/1878-0261.12668

Ejemplares similares

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

Phospholipase C Isozymes Are Deregulated in Colorectal Cancer – Insights Gained from Gene Set Enrichment Analysis of the Transcriptome
por: Danielsen, Stine A., et al.
Publicado: (2011)

Genomic characterization of ependymomas reveals 6q loss as the most common aberration
por: OLSEN, THALE KRISTIN, et al.
Publicado: (2014)

Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability
por: Flatin, Bjørnar T.B., et al.
Publicado: (2020)

Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
por: Sveen, Anita, et al.
Publicado: (2011)

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer
por: Cekaite, Lina, et al.
Publicado: (2015)

A robust internal control for high-precision DNA methylation analyses by droplet digital PCR
por: Pharo, Heidi D., et al.
Publicado: (2018)

Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients
por: Lind, Guro E., et al.
Publicado: (2017)

Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours – A prognostic test after surgical resection
por: Kolberg, Matthias, et al.
Publicado: (2015)

Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer
por: Bergsland, Christian H., et al.
Publicado: (2022)

PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data
por: Jeanmougin, Marine, et al.
Publicado: (2022)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
por: Kleivi, Kristine, et al.
Publicado: (2007)

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
por: Lind, Guro E, et al.
Publicado: (2004)

ADAMTS1, CRABP1, and NR3C1 Identified as Epigenetically Deregulated Genes in Colorectal Tumorigenesis
por: Lind, Guro E., et al.
Publicado: (2006)

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
por: Vedeld, Hege Marie, et al.
Publicado: (2017)

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2018)

Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2014)

Immune Microenvironment in Glioblastoma Subtypes
por: Chen, Zhihong, et al.
Publicado: (2018)

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer
por: Vedeld, Hege Marie, et al.
Publicado: (2014)

Pediatric spinal ependymomas: an unpredictable and puzzling disease. Long-term follow-up of a single consecutive institutional series of ten patients
por: Lundar, Tryggve, et al.
Publicado: (2014)

A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
por: Skotheim, Rolf I, et al.
Publicado: (2009)

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
por: Kolberg, Matthias, et al.
Publicado: (2013)

Myeloid leukemia with t(7;21)(p22;q22) and 5q deletion
por: PANAGOPOULOS, IOANNIS, et al.
Publicado: (2013)

Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
por: Ahlquist, Terje, et al.
Publicado: (2008)

Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
por: Berg, Marianne, et al.
Publicado: (2010)

A Tissue-Based Comparative Effectiveness Analysis of Biomarkers for Early Detection of Colorectal Tumors
por: Ahmed, Deeqa, et al.
Publicado: (2012)

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
por: Dienstmann, R, et al.
Publicado: (2019)

Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties
por: Eide, Peter W., et al.
Publicado: (2019)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
por: Kresse, Stine H., et al.
Publicado: (2023)

Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors
por: Burum-Auensen, Espen, et al.
Publicado: (2010)

Hypermethylated MAL gene – a silent marker of early colon tumorigenesis
por: Lind, Guro E, et al.
Publicado: (2008)

Cerebral palsy in Moldova: subtypes, severity and associated impairments
por: Gincota Bufteac, Ecaterina, et al.
Publicado: (2018)

Evaluation of Memorial Sloan‐Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma
por: Jahr, Guro, et al.
Publicado: (2018)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Experimental factors affecting the robustness of DNA methylation analysis
por: Pharo, Heidi D., et al.
Publicado: (2016)

Transcriptome instability as a molecular pan-cancer characteristic of carcinomas
por: Sveen, Anita, et al.
Publicado: (2014)

Tumor Spreading to the Contralateral Ovary in Bilateral Ovarian Carcinoma Is a Late Event in Clonal Evolution
por: Micci, Francesca, et al.
Publicado: (2010)

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9bntpg39rmbn2og7lf3iccpjsa